The MAPK / JNK Signalling Pathway Offers Potential Therapeutic Targets for the Prevention of Acquired Deafness

E-ISSN： 2212-5299|3|4|325-332

ISSN： 1568-007X

Source： Current Drug Targets-CNS & Neurological Disorders, Vol.3, Iss.4, 2004-08, pp. : 325-332

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential therapeutic targets in the rapidly expanding field of purinergic signalling

By Burnstock G

Clinical Medicine, Vol. 2, Iss. 1, 2002-01 ,pp. : 45-53

Royal College Of Physicians

Access to resources Recommend Favorite

The JNK pathway as a therapeutic target for diabetes

By Kaneto Hideaki

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 581-592

Informa Healthcare

Access to resources Recommend Favorite

Targeting the JNK Pathway for Therapeutic Benefit in CNS Disease

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 1, 2002-02 ,pp. : 31-49

Bentham Science Publishers

Access to resources Recommend Favorite

Ammonium Activates Ouabain-Activated Signalling Pathway in Astrocytes: Therapeutic Potential of Ouabain Antagonist

Current Neuropharmacology, Vol. 12, Iss. 4, 2014-07 ,pp. : 334-341

Bentham Science Publishers

Access to resources Recommend Favorite

Potential therapeutic targets for schizophrenia

By Wong A.H. Sanyal S. Knapp M.G. van Tol H.H.

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 4, 1999-12 ,pp. : 571-586

Informa Healthcare

Access to resources Recommend Favorite